Enveric Biosciences, Inc. (ENVB)
5.455
+0.02
(+0.28%)
USD |
NASDAQ |
Dec 12, 12:01
Enveric Biosciences Total Liabilities (Quarterly): 0.9059M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AbbVie, Inc. | 136.50B |
| Pasithea Therapeutics Corp. | 1.424M |
| CEL-SCI Corp. | 13.31M |
| AIM ImmunoTech, Inc. | 11.57M |
| IGC Pharma, Inc. | 1.651M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.362M |
| Shareholders Equity (Quarterly) | 3.456M |
| Current Ratio | 4.561 |